First AMCM M290-2 FLX Industrial Printer with nLIGHT in North America Delivered to Sintavia
System represents a huge leap forward in productivity and performance for powder bed fusion applications
Sintavia, LLC, the world’s leading all-digital aerospace component manufacturer, announced today that it had commissioned the first multi-laser industrial 3D printer in North America equipped with nLIGHT AFX beam shaping fiber laser systems. The state-of-the-art twin 1.2 kW lasers, installed on an AMCM M290-2, allow for operators of industrial 3D printers to modulate beam spot size and shape without any loss of power and material density, resulting in builds that are more productive and less wasteful.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250228406053/en/

AMCM M290-2 FLX Printer (left); Difference between normal Gaussian laser spot and nLIGHT laser spot (right) (Photo: Business Wire)
“We welcome this new addition to our fleet of printers,” said Brian Neff, Sintavia’s Founder and CEO. “Over the coming years as we develop and apply this new technology, we expect to be able to print our components at layer thicknesses of 150µm or more without losing any material properties, thus greatly increasing the output of our installed printers. The best part of the nLIGHT system, once it is fully tested, is that it can be retrofitted on other existing EOS and AMCM printers with minimal new equipment.”
“We can think of no better home for the first dual nLIGHT system in the U.S. than Sintavia,” said Martin Bullemer, Managing Director of AMCM, GmbH. “With their vertically integrated additive manufacturing capabilities, including extensive testing labs, they are well-suited to help develop and expand the capabilities of the nLIGHT laser beam shaping technology.”
Laser beam shaping systems such as nLIGHT offer a step-function in laser productivity over the Gaussian laser shape that is standard across the powder bed fusion (PBF) additive manufacturing industry today. Beam shaping allows for fully dense material to be melted at a diameter over three times greater than standard laser systems, meaning that standard layer thicknesses currently used by the industry (typically 30-45µm) can be doubled or tripled without any loss of material performance. At the same time, since a part can now be printed using fewer layers, less condensate (the metal vapor jet generated during the PBF process) is produced. Condensate is the most problematic byproduct of the PBF process, and studies have shown that the use of nLIGHT beam shaping lasers can reduce this waste stream by up to 70%. Finally, by fully melting thicker build layers without losing density, grain size in the z-direction is increased, resulting in improved material performance—in particular for those applications with high creep requirements.
About Sintavia
Sintavia is the leading all-digital component manufacturer supplying the aerospace and defense industry. The company uses a vertically integrated design and additive manufacturing capability, combined with a seamless digital production thread, to deliver next generation power and thermodynamic components, such as heat exchangers, combustors, and pumps, to lead systems integrators globally. Sintavia’s additively designed and manufactured components include the first metal AM components to ever be installed on a fighter jet and a nuclear-powered submarine. For more information visit http://www.sintavia.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250228406053/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 22:30:00 CEST | Press release
Company’s AML drug program is focused on both newly diagnosed and relapsed/refractory FLT3-positive AML, overcoming major forms of resistance to FDA-approved FLT3 inhibitors, and outperforms other investigational inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to exi
IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 22:05:00 CEST | Press release
IonQ and Einride will collaborate to develop quantum solutions for fleet routing, logistics optimization, and supply chain solutionsIonQ’s investment will grow its European presence and reinforce commitment to building a quantum economy in Sweden and the European market IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global frei
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 21:26:00 CEST | Press release
Company’s NSCLC drug program is focused on overcoming both mutational and non-mutational resistance to 3rd-generation EGFR inhibitors and outperforms other investigational 4th-generation inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current s
NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 21:24:00 CEST | Press release
NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates
Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 21:08:00 CEST | Press release
As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom